← Back to headlines
Medtronic's MiniMed Diabetes Business Seeks $784M in US IPO
Medtronic's diabetes business unit, MiniMed, is reportedly planning an Initial Public Offering (IPO) in the United States, aiming to raise $784 million.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
